6th Jun 2017 07:00
For immediate release | 6 June 2017 |
Quantum Pharma Plc
('Quantum' or the 'Company')
Annual Report and Accounts
Notice of Annual General Meeting
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that in accordance with AIM Rule 20, electronic copies of its Annual Report and Accounts for the year ended 31 January 2017 together with the Notice of Annual General Meeting and Form of Proxy are available from the Company's investor relations website at http://ir.quantumpharmagroup.com/ . Hard copies of the 2017 Annual Report and Accounts, Notice of Annual General Meeting and Form of Proxy were posted to shareholders yesterday.
The Company's Annual General Meeting will be held at 1:00 p.m. on Thursday, 6 July 2017 at the offices of Muckle LLP, Time Central, 32 Gallowgate, Newcastle upon Tyne, NE1 4BF.
- Ends -
For further information: Quantum Pharma Plc |
|
Chris Rigg, Chief Executive Officer | Tel: +44 (0) 1207 279 404 |
Gerard Murray, Chief Financial Officer | www.quantumpharmaplc.com |
ir@quantumpharma.co.uk |
|
N+1 Singer |
|
(Nominated Advisor & Broker) |
|
Sandy Fraser / Nick Owen / James White | Tel: +44 (0) 20 7496 3000 |
Media enquiries: Buchanan |
|
Henry Harrison-Topham / Sophie Cowles | Tel: +44 (0) 20 7466 5000 |
quantumpharma@buchanan.uk.com | www.buchanan.uk.com |
Notes to Editors
Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital and homecare markets. Quantum Pharma Plc operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.
For further information, please visit www.quantumpharmaplc.com.
Related Shares:
Quantum Pharma